Art

J-GLOBAL ID：202002288515058454   Reference number：20A1015222

Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells

PC3前立腺癌細胞におけるエイコサペンタエン酸(EPA)の抗癌効果に対するPYK2経路と活性酸素種(ROS)の寄与【JST・京大機械翻訳】

Author (6)： Oono Keiichi (Laboratory of Physiology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan) ,  Ohtake Kazuo (Laboratory of Physiology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan) ,  Watanabe Chie (Laboratory of Clinical Pathology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan) ,  Shiba Sachiko (Laboratory of Physiology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan) ,  Sekiya Takashi (Laboratory of Clinical Pathology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan) ,  Kasono Keizo (Laboratory of Physiology, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan)
Material： Lipids in Health and Disease (Web)
Volume： 19  Issue： 1  Page： 1-12  Publication year： 2020 
JST Material Number： U7391A  ISSN： 1476-511X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： n-3 polyunsaturated fatty acid...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1015222&from=J-GLOBAL&jstjournalNo=U7391A") }}

Thesaurus term： immersional wetting ,  *antitumor action ,  antibody ,  growth inhibition ,  phosphorylation ,  cardiovascular disease ,  protective action ,  in vitro experiment ,  tyrosine kinase ,  Western blotting ,  ERK ,  Cell Survival ,  PC-3 Cells ,  *prostate cancer cells ,  bioassay ,  amino acid ,  nitrogen heterocyclic compound

Author keywords (5)： PC3 ,  EPA ,  ROS ,  ERK ,  Pyk2

JST classification (2)： Biological function  (EB05020M) ,  Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Substance index (1)： Proline

Reference (53)：

• JAMA Oncol; Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study; C Fitzmaurice, TF Akinyemiju, FH Lami, T Alam, R Alizadeh-Navaei, C Allen, U Alsharif, N Alvis-Guzman, E Amini; 4; 11; 2018; 1553-1568; 10.1001/jamaoncol.2018.2706; citation_id=CR1
• Int J Urol; Epidemiology of prostate cancer in Asian countries; T Kimura, S Egawa; 25; 6; 2018; 524-531; 10.1111/iju.13593; citation_id=CR2
• F1000Res; Recent trends in the management of advanced prostate cancer; C Ritch, M Cookson; 21; 2018; 7; citation_id=CR3
• Cancer; The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer; EJ Small, S Srinivas; 76; 8; 1995; 1428-1434; 10.1002/1097-0142(19951015)76:8<1428::AID-CNCR2820760820>3.0.CO;2-T; citation_id=CR4
• Transl Androl Urol; Chemotherapy and radiation for prostate cancer; MD Hurwitz; 7; 3; 2018; 390-398; 10.21037/tau.2018.03.07; citation_id=CR5

Terms in the title (8)： 前立腺癌細胞 ,  エイコサペンタエン酸 ,  EPA ,  抗癌効果 ,  PYK2 ,  経路 ,  活性酸素種 ,  ROS